Clinical validation of inertial sensing-based wearable device for tremor and Bradykinesia quantification

Clinical validation of inertial sensing-based wearable device for tremor and Bradykinesia quantification
ISWD for the quantification of Parkinsonian tremors and bradykinesia. Credit: Prof. DAI's group

Parkinson's disease (PD) is characterized by motor symptoms such as tremor, rigidity, bradykinesia, and problems with gait. However, neurologists judge the severity of Parkinsonian motor symptoms according to clinical scales, and their judgments are inconsistent because of differences in clinical experiences.

Nowadays, with the rapid development of micro-electromechanical systems sensor technology and population aging around the globe, inertial sensing-based wearable devices (ISWDs), have tended to obtain the accurate and objective of PD .

In order to investigate the effectiveness ISWDs for Parkinsonian symptoms quantification, a research team led by Prof. Dai Houde from the Fujian Institute of Research on the Structure of Matter of the Chinese Academy of Sciences carried out a systematic investigation for the performance evaluation of the ISWD outputs. Relevant study was published in IEEE Journal of Biomedical and Health Informatics.

The researchers found that inconsistency existed among the judgments of neurologists, while the quantification performance (sensitivity, specificity, and accuracy) of ISWD were better than the neurologists.

For the assessment scales other than MDS-UPDRS, the proposed method in this study is valid as long as there is a quantitative parameter for each assessment task.

They improved the performance of ISWDs with more accurate labels, i.e., ground truths, from high-precision 6-axis motion tracking systems such as an electromagnetic tracking system (EMTS), instead of only via the advanced algorithms such as machine learning and deep learning.

In addition, this EMTS can be regarded as a training tool for improving the diagnostic skills of young neurologists.

The study demonstrated that the ISWDs can not only offer physicians effective help for an accurate assessment of the bradykinesia severity, but also serve as a self-monitor setting at home for the patients themselves.


Explore further

Machine learning leads to novel way to track tremor severity in Parkinson's patients

More information: Houde Dai et al. Validation of Inertial Sensing-based Wearable Device for Tremor and Bradykinesia Quantification, IEEE Journal of Biomedical and Health Informatics (2020). DOI: 10.1109/JBHI.2020.3009319
Citation: Clinical validation of inertial sensing-based wearable device for tremor and Bradykinesia quantification (2020, September 2) retrieved 22 September 2020 from https://medicalxpress.com/news/2020-09-clinical-validation-inertial-sensing-based-wearable.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments